Budget-Impact of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Greece

OBJECTIVES: To estimate the budgetary impact for the National Organization for Healthcare Provision (EOPYY) in Greece of adopting selexipag in insufficiently-controlled functional class (FC) III patients with pulmonary arterial hypertension (PAH) in triple therapy with endothelin receptor agonist (E...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A641-A642
Hauptverfasser:	Solakidi, A, Tzanetakos, C, Bilir, SP, Beaudet, A, Zervoudaki, A, Lamprou, C, Maniadakis, N
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost control Critical incidents Endothelins Epidemiology Health care expenditures Hypertension Impact analysis Management Market shares Medical treatment Mortality Patients Phosphodiesterase Prices Prostacyclin Pulmonary arteries Pulmonary hypertension Savings Sensitivity analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!